Lu-177-labeled 6A10 Fab-fragments
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lu-177-labeled 6A10 Fab-fragments, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Radioimmunotherapy with Lu-177 Labeled 6A10 Fab-fragments in Patients with Glioblastoma After Standard Treatment [Phase 1]